CLINICAL_TRIALS
trial_result
· 2022-04-12
Clinical Trial Update: Blood Brain Barrier Opening in Alzheimer' Disease [Phase 1, Phase 2]
Summary
Phase 1/2 trial exploring blood-brain barrier opening in Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED